What does nonoperating income expense milestone income mean?

This metric captures revenue recognized from the achievement of specific development, regulatory, or commercial milestones stipulated in collaboration or licensing agreements. It serves as an indicator of progress in the company's research and development pipeline as validated by external partners. Monitoring this income helps investors evaluate the efficacy of the company's partnership model and the timing of cash inflows from collaborative drug development programs.

Theravance Biopharma TBPH Nonoperating Income Expense Milestone Income

Nonoperating Income Expense Milestone Income at other companies

Crinetics PharmaceuticalsCRNX

$1.5M—

Axsome TherapeuticsAXSM

$500K—

Dianthus TherapeuticsDNTH

$15M0.0%

Dianthus TherapeuticsDNTH

$7M+600%

Nuvation BioNUVB

$21.2M—

Tarsus Pharmaceuticals, Inc.TARS

$3M0.0%

Segments

By segment

See full

Single Reportable$50M—

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$896.51M+68.7%

Enterprise value$648.91M+38.3%

P/E7.8×—

P/S8.2×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept tbph:NonoperatingIncomeExpenseMilestoneIncome.

The official record: Theravance Biopharma’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's nonoperating income expense milestone income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's nonoperating income expense milestone income?: Theravance Biopharma (TBPH) reported nonoperating income expense milestone income of $50M in Q4 2025.
What does nonoperating income expense milestone income mean?: This metric captures revenue recognized from the achievement of specific development, regulatory, or commercial milestones stipulated in collaboration or licensing agreements. It serves as an indicator of progress in the company's research and development pipeline as validated by external partners. Monitoring this income helps investors evaluate the efficacy of the company's partnership model and the timing of cash inflows from collaborative drug development programs.